Effects of haemodialysis on circulating endothelial progenitor cell count

Blood Purification

Volumn 25, Issue 3, 2007, Pages 242-251

  Sturiale, Alessio ^a   Coppolino, Giuseppe ^a   Loddo, Saverio ^a   Criseo, Manila ^a   Campo, Susanna ^a   Crascì, Eleonora ^a   Bolignano, Davide ^a   Nostro, Lorena ^a   Teti, Diana ^a   Buemi, Michele ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Cardiovascular risk factors; Endothelial progenitor cells; Vascular endothelial growth factor receptor

Indexed keywords

CALCIUM; CALCIUM ANTAGONIST; CD133 ANTIGEN; CD34 ANTIGEN; CHOLESTEROL; CREATININE; DIURETIC AGENT; NITRATE; PHOSPHATE; PHOSPHATE BINDING AGENT; UREA; VASCULOTROPIN RECEPTOR 2; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD34 SELECTION; CELL COUNT; CELL MATURATION; CHOLESTEROL BLOOD LEVEL; CHRONIC PYELONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEMATOPOIETIC STEM CELL; HEMODIALYSIS; HUMAN; HUMAN CELL; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; MALE; PHOSPHATE BLOOD LEVEL; POPULATION RISK; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; STEM CELL; STEM CELL MOBILIZATION; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

ADULT; AGED; ANTIGENS, DIFFERENTIATION; BLOOD CELL COUNT; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HEMATOPOIETIC STEM CELLS; HEMORHEOLOGY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY; RENAL DIALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34447558475     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101697     Document Type: Article

References (41)

1. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-1615.
2. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003;85:S105-S110.
3. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141.
4. Buemi M, Aloisi E, Coppolino G, Loddo S, Crasci E, Aloisi C, Barilla A, Cosentini V, Nostro L, Caccamo C, Floccari F, Romeo A, Frisina N, Teti D: The effect of two different protocols of potassium haemodiafiltration on QT dispersion. Nephrol Dial Transplant 2005;20:1148-1154.
5. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
6. Annuk M, Zilmer M, Fellstrom B: Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int Suppl 2003;84:S50-S53.
7. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S: Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-2516.
8. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: new hope for a broken heart. Circulation 2003;107:3093-3100.
9. Patterson C: The Ponzo effect: endothelial progenitor cells appear on the horizon. Circulation 2003;107:2995-2997.
10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: Estimation of tenyear risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
11. Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT: Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells: prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol 1999;21:301-308.
12. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):S112-S119.
13. Braunschweig F, Kjellstrom B, Soderhall M, Clyne N, Linde C: Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor. Nephrol Dial Transplant 2006;21:176-183.
14. Ronco C, Bowry S, Tetta C: Dialysis patients and cardiovascular problems: can technology help solve the complex equation? Blood Purif 2006;24:39-45.
15. Bolasco P, Altieri P, Andrulli S, Basile C, Di Filippo S, Feriani M, Pedrini L, Santoro A, Zoccali C, Sau G, Locatelli F: Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant 2003;18(suppl 7):vii50-54, discussion vii59-62.
16. Hillebrands JL, Klatter FA, Rozing J: Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2003;23:380-387.
17. Rosenzweig A: Endothelial progenitor cells. N Engl J Med 2003;348:581-582.
18. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M: Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000;95:2813-2820.
19. Buemi M, Allegra A, D'Anna R, Coppolino G, Crascì E, Giordano D, Loddo S, Cucinotta M, Musolino C, Teti D: Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol 2007;196:68.e1-68.e6.
20. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
21. Eizawa T, Murakami Y, Matsui K, Takahashi M, Muroi K, Amemiya M, Takano R, Kusano E, Shimada K, Ikeda U: Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003;19:627-633.
22. Herbrig K, Pistrosch F, Oelschlaegel U, Wichmann G, Wagner A, Foerster S, Richter S, Gross P, Passauer J: Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004;44:840-849.
23. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S: Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102:1340-1346.
24. Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T: Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 1999;59:5875-5877.
25. Buemi M, Corica F, Marino D, Medici MA, Aloisi C, Di Pasquale G, Ruello A, Sturiale A, Senatore M, Frisina N: Cardiovascular remodeling, apoptosis, and drugs. Am J Hypertens 2000;13:450-454.
26. Buemi M, Allegra A, Corica F, Aloisi C, Ruello A, Giacobbe MS, Di Pasquale G, Senatore M, Frisina N: Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration. Am J Hypertens 1999;12:73-75.
27. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A: Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006;26:2140-2146.
28. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
29. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
30. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246-1252.
31. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J: Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 2005;46:1693-1701.
32. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370-1376.
33. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006;4:566-573.
34. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-3388.
35. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ: Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213-3220.
36. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L: Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
37. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S: Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 2001;88:167-174.
38. Chan CT, Li SH, Verma S: Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol 2005;289:F679-F684.
39. Laufs U, Urhausen A, Werner N, Scharhag J, Heitz A, Kissner G, Bohm M, Kindermann W, Nickenig G: Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 2005;12:407-414.
40. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
41. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS: Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005;67:1078-1083.